全文获取类型
收费全文 | 12659篇 |
免费 | 1245篇 |
国内免费 | 68篇 |
专业分类
耳鼻咽喉 | 107篇 |
儿科学 | 317篇 |
妇产科学 | 235篇 |
基础医学 | 1900篇 |
口腔科学 | 457篇 |
临床医学 | 1343篇 |
内科学 | 2415篇 |
皮肤病学 | 335篇 |
神经病学 | 1123篇 |
特种医学 | 598篇 |
外科学 | 2041篇 |
综合类 | 236篇 |
一般理论 | 11篇 |
预防医学 | 1252篇 |
眼科学 | 171篇 |
药学 | 705篇 |
2篇 | |
中国医学 | 4篇 |
肿瘤学 | 720篇 |
出版年
2021年 | 184篇 |
2020年 | 139篇 |
2019年 | 190篇 |
2018年 | 203篇 |
2017年 | 170篇 |
2016年 | 182篇 |
2015年 | 196篇 |
2014年 | 311篇 |
2013年 | 466篇 |
2012年 | 703篇 |
2011年 | 763篇 |
2010年 | 435篇 |
2009年 | 356篇 |
2008年 | 731篇 |
2007年 | 711篇 |
2006年 | 654篇 |
2005年 | 635篇 |
2004年 | 623篇 |
2003年 | 570篇 |
2002年 | 590篇 |
2001年 | 248篇 |
2000年 | 248篇 |
1999年 | 216篇 |
1998年 | 162篇 |
1997年 | 168篇 |
1996年 | 151篇 |
1995年 | 127篇 |
1994年 | 124篇 |
1993年 | 126篇 |
1992年 | 187篇 |
1991年 | 200篇 |
1990年 | 182篇 |
1989年 | 157篇 |
1988年 | 210篇 |
1987年 | 162篇 |
1986年 | 153篇 |
1985年 | 151篇 |
1984年 | 130篇 |
1983年 | 118篇 |
1982年 | 135篇 |
1981年 | 120篇 |
1980年 | 103篇 |
1979年 | 100篇 |
1978年 | 106篇 |
1977年 | 76篇 |
1976年 | 80篇 |
1975年 | 90篇 |
1974年 | 82篇 |
1973年 | 90篇 |
1972年 | 74篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
81.
82.
Picotamide inhibition of excess in vitro thromboxane B2 release by colorectal mucosa in inflammatory bowel disease. 总被引:1,自引:0,他引:1
Collins CE Benson MJ Burnham WR Rampton DS 《Alimentary pharmacology & therapeutics》1996,10(3):315-320
BACKGROUND: Inflammatory bowel disease is associated with increased mucosal release of eicosanoids. Among these, thromboxane A2 has been proposed as a possible inflammatory mediator; its suppression may be a useful therapeutic option. METHODS: Using a tissue incubation technique, we compared release of immunoreactive thromboxane B2 by colonic biopsies from patients with ulcerative colitis, Crohn's disease and controls, and assessed the inhibitory effect of picotamide, a thromboxane synthesis inhibitor-receptor antagonist, which has been widely used in Italy for management of ischaemic heart and cerebrovascular disease. RESULTS: Increased amounts of thromboxane B2 were released from biopsies from patients with active ulcerative colitis (median 238 pg/20 min/mg wet weight (interquartile range 147- 325), n = 12) and active Crohn's disease (252 (174-450), 6) compared with those from patients with quiescent ulcerative colitis (95 (61- 140), 12) or Crohn's disease (105 (57-201), 13), or controls (136 (64- 206), 8). Incubation with picotamide at concentrations between 100 microM and 1 mM reduced thromboxane B2 release (IC50 890 microM). CONCLUSION: Since increased thromboxane A2 production may have pathogenetic importance, thromboxane synthesis inhibitor-receptor antagonists such as picotamide merit therapeutic trial in the management of inflammatory bowel disease. 相似文献
83.
84.
85.
Anderson RA; Evans LW; Irvine DS; McIntyre MA; Groome NP; Riley SC 《Human reproduction (Oxford, England)》1998,13(12):3319-3325
Follistatin is a binding protein for the activin and inhibin family of
hormones, regulating their biological activity. In the male reproductive
tract, the interaction of these factors is likely to be involved in the
regulation of the proliferation of several cell types. We have investigated
the presence of follistatin and activin A in seminal plasma using specific
immunoassays and have localized follistatin and activin/inhibin subunits in
the adult human testis, prostate and seminal vesicle to establish their
likely sources. High concentrations of immunoreactive follistatin were
present in seminal plasma in normal men (mean 97.9 ng/ml; 1.43 ng/ml in
peripheral plasma) and were similar in men with oligo/azoospermia and
following vasectomy. Follistatin immunoreactivity was localized to both
Leydig and Sertoli cells of the testis, and to epithelial cells of the
prostate gland and seminal vesicle, which are likely to be the predominant
sources of the hormone in seminal plasma. Activin A was also present in
seminal plasma in normal men but was undetectable following vasectomy, thus
deriving from the testis. Consistent with this finding, the betaA-subunit
was immunolocalized in Sertoli and Leydig cells but was not present in
seminal vesicle or prostate gland. The functional significance of the high
concentrations of follistatin secreted into seminal plasma by the prostate
gland and/or seminal vesicle is uncertain, but they may regulate the
biological activity of testis-derived activin A and inhibin B.
相似文献
86.
87.
88.
Dr. Julie A. Porter Pharm.D. Dr. Barry L. Carter Pharm.D. FCCP Dr. Thomas P. Johnston Ph.D. Dr. Warren K. Palmer Ph.D. 《Pharmacotherapy》1995,15(1):92-98
A new animal model of hyperlipidemia is being developed using the nonionic surfactant poloxamer 407 (P-407). We investigated the impact of pravastatin on P-407-induced hyperlipidemia. Twenty rats received P-407 300 mg intraperitoneally to induce hyperlipidemia, and 20 control rats received saline injection. Pravastatin was administered orally to an equal number of rats in both groups using three different regimens. A fourth group did not receive pravastatin. At 24 hours after injection, total cholesterol levels in two of the pravastatin groups were 28% and 34% lower than those in animals that did not receive pravastatin (p≤0.01). At 48 hours, triglyceride levels were significantly lower in all pravastatin groups (21–44%) versus animals not receiving pravastatin. Pravastatin diminished the effects of P-407 on lipoproteins. This new animal model may be useful in screening for investigational antihyperlipidemic agents. 相似文献
89.
George Szasz M.D. M. G. McLoughlin F.R.C.S. F.A.C.S. R. J. Warren M.D. F.R.C.S. 《Archives of sexual behavior》1990,19(4):343-348
The penis, scrotum, and testicles of a 31-year-old man were cut off in a fight. Fourteen hours later the penis and one testicle were reattached, but the testicle later had to be removed. By 3 weeks normal urinary function returned but the penis was misshapen. The patient had suicidal intentions. His partner was sexually supportive but afraid to touch the penis. By 10 weeks penile swelling occurred in response to a movie with frank sexual content. By 12 weeks the penile swelling was sufficient for entry but the partner was acutely afraid that her vaginal contractions would tear the scars. The man was concerned because he experienced only mild sexual tensions. Physical examination reassured both, and they gained hope for recovery. At 16 weeks erections were still not full but active intercourse was attempted and he experienced seminal seepage and mild orgasmic sensations; she was relaxed enough to have orgasm. Testosterone was administered at regular intervals from the 19th week on, with immediate improvement of erection. By 32 weeks full erection, ejaculation, and orgasmic functions returned and the couple resumed their normal sexual practices. 相似文献
90.